Effects of High-Dose Oxygen on Heart Function in Patients with Pulmonary Vascular Disease at High Altitude
Author Information
Author(s): Müller Julian, Lichtblau Mona, Saxer Stéphanie, Schmucki Mirjam, Furian Michael, Schneider Simon R, Herzig Joël J, Bauer Meret, Saragoni Diego, Schwarz Esther I, Cajamarca Elizabeth, Hoyos Rodrigo, Ulrich Silvia
Primary Institution: University Hospital Zurich
Hypothesis
Does high-dose supplemental oxygen improve pulmonary haemodynamics in patients with pulmonary vascular disease living at high altitude?
Conclusion
High-dose oxygen therapy significantly lowered systolic pulmonary artery pressure but also cardiac output in patients with pulmonary vascular disease living at high altitude.
Supporting Evidence
- High-dose oxygen therapy reduced systolic pulmonary artery pressure by 11 mmHg.
- Cardiac output decreased by 0.7 L/min with oxygen therapy.
- 46% of patients responded to oxygen therapy with a significant reduction in pulmonary artery pressure.
Takeaway
Breathing in a lot of oxygen can help some people with lung problems feel better, especially if they live high up in the mountains.
Methodology
This was a randomized, single-blind, placebo-controlled crossover trial where patients received both oxygen and placebo air in random order.
Potential Biases
The investigators were not blinded to the study intervention.
Limitations
The study used a high dose of oxygen, and the effects of lower doses are unknown; the sample size was small.
Participant Demographics
28 patients with pulmonary vascular disease, predominantly female (24 females), aged 45 ± 12 years.
Statistical Information
P-Value
<0.001
Confidence Interval
−15 to −6 mmHg
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website